Endocrinology

Latest News

5 pediatric FDA decisions to watch for in Q4 2025 | Image credit: Contemporary Pediatrics

Key pediatric FDA decisions to watch for in Q4 2025

September 30th 2025

From another potential treatment for pediatric atopic dermatitis, to STI therapy for uncomplicated urogenital gonorrhea, take a look ahead at key PDUFA dates in Q4.

Tirzepatide effective in reducing A1c in children, adolescents with type 2 diabetes

By Joshua Fitch, Senior Editor

September 19th 2025

Michael Haller, MD, discusses safety and use for inhaled insulin in T1D

By Michael Haller, MD

August 18th 2025

Richard Auchus, MD, on how crinecerfont is changing CAH treatment

By Richard Auchus, MD, PhD

August 14th 2025

FDA accepts NDA for ET-600, desmopressin oral solution for pediatric AVP deficiency

By Morgan Ebert, Managing Editor

July 8th 2025

Latest CME Events & Activities

More News

Diabetic Ketoacidosis in Children:

Stuart A. Bradin, DO

October 1st 2006

As our children are becoming fatter, diabetes is becoming more common. Diabetic ketoacidosis (DKA) can lead to cerebral edema, a complication unique to the pediatric population and a common cause of death in this young group.

Case In Point: Infant With Aldosterone Deficiency

Nedim Akan, MD;Prasad Lakshminarasimhiah, MD;Chandra Edwin, MD;Deepak M. Kamat, MD, PhD

September 1st 2006

A 45-day-old boy was referred for evaluation of persistent hyponatremia and hyperkalemia. On the 9th day of the boy's life, his serum potassium level was elevated (8 mEq/L) and on the 12th day, his serum sodium level was low (131 mEq/L). Supplementation with sodium chloride was initiated.

Type 2 Diabetes Mellitus in Children:A New Challenge for Diagnosis and Prevention

Josephine Ho, MD;Danile Pacaud, MD;Alexander K. C. Leung, MD

February 1st 2006

Key words: type 2 diabetes melllitus, childhood obesity

Consultations & Comments: Why the Spotlight on Obesity?

Kathleen C. Moltz, MD

June 1st 2005

Consultations & Comments:

<1 2 3

About Us

Advertise

Editorial